DossierENTITY

Erez Israeli

Coverage of Erez Israeli in the Nexus archive.

Earliest in view: Jul 30 · 06:24 UTCMost recent: Jul 30 · 06:24 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJul 30 · 06:24 UTCBLOOMBERG
Dr Reddy's CEO On Clogged Semaglutide Pipeline
Dr Reddy's CEO Erez Israeli anticipates strong performance in the second half of FY2026-27 after resolving semaglutide pipeline issues. He predicts intense competition in the semaglutide generics market, with over 20 companies vying for market share.